Letrozole's superiority over progestins and tamoxifen challenges standards of care in endocrine therapy for metastatic breast cancer.


Piccart M., Cardoso F., Atalay G.

European journal of cancer (Oxford, England : 1990), 2002 (SCI-Expanded) identifier identifier identifier